Neuronoff INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCleveland, OH
SAM.gov UEIVNH8CLTF2X41
Neuronoff develops the Injectrode, an implant system designed to treat chronic pain and neurogenic bladder in spinal cord injury patients. The system includes an IPG, receiver, and adapter. The company has received 510(k) clearance and is conducting a clinical trial funded by the Department of Defense.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Neuronoff INC | Cleveland | OH | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.